CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-18 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −1,625 | 1,625 | ||
| 2018-12-18 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +1,075 | 79,951 | ||
| 2018-12-18 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −306 | $6.30 | $2K | 79,645 |
| 2018-12-18 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −1,075 | 1,075 | ||
| 2018-12-15 | Walker Neal President and CEO | Option exercise | +3,033 | 908,895 | ||
| 2018-12-15 | Walker Neal President and CEO | Shares withheld for taxes | −863 | $7.31 | $6K | 908,032 |
| 2018-12-15 | Walker Neal President and CEO | Option exercise · Restricted Stock Units | −3,033 | 6,067 | ||
| 2018-12-15 | Ruffo Frank Chief Financial Officer | Option exercise | +1,300 | 161,885 | ||
| 2018-12-15 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −370 | $7.31 | $3K | 161,515 |
| 2018-12-15 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −1,300 | 2,600 | ||
| 2018-12-15 | Shanler Stuart Chief Scientific Officer | Option exercise | +1,300 | 268,812 | ||
| 2018-12-15 | Shanler Stuart Chief Scientific Officer | Shares withheld for taxes | −370 | $7.31 | $3K | 268,442 |
| 2018-12-15 | Shanler Stuart Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,300 | 2,600 | ||
| 2018-12-15 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +1,733 | 79,369 | ||
| 2018-12-15 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −493 | $7.31 | $4K | 78,876 |
| 2018-12-15 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −1,733 | 3,467 | ||
| 2018-12-15 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +1,300 | 138,621 | ||
| 2018-12-15 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −357 | $7.31 | $3K | 138,264 |
| 2018-12-15 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −1,300 | 2,600 | ||
| 2018-12-15 | Fair Brett Chief Commercial Officer | Option exercise | +1,013 | 7,051 |
Page 44 of 47 · 928 trades